Literature DB >> 18752109

Schizophrenia and sudden cardiac death: a review.

Hannu Koponen1, Antti Alaräisänen, Kaisa Saari, Olavi Pelkonen, Heikki Huikuri, M J Pekka Raatikainen, Markku Savolainen, Matti Isohanni.   

Abstract

Schizophrenia is a devastating mental disorder, which is often associated with severe loss of functioning and shortened life expectancy. Suicides and accidents are well-known causes of the excess mortality, but patients with schizophrenia have also been reported to be three times as likely to experience sudden unexpected death as individuals from the general population. This review is aimed to offer an update of the prevalence and mechanisms for sudden cardiac death in schizophrenia. The PubMed database was searched from 1966 up to May 2007 with key words schizophrenia AND " sudden cardiac death" OR "autonomic dysfunction" OR "torsades de pointes". Part of the high death rates may be explained by long-lasting negative health habits, disease- and treatment-related metabolic disorders, and consequent increased frequencies of cardiovascular diseases. The antipsychotic medications may also increase the risk as some antipsychotics may cause prolongation of QT-time, serious ventricular arrhythmias and predispose to sudden death. Autonomic dysfunction seen as low heart rate variability and decreased baroreflex sensitivity may also contribute via malignant arrhythmias. Due to the complex interaction of various risk factors for sudden death, the patients need a comprehensive follow-up of their physical health. In addition, more studies on the role and prevalence of autonomic dysfunction in psychotic patients are needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752109     DOI: 10.1080/08039480801959323

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  32 in total

1.  Premature death in adults with 22q11.2 deletion syndrome.

Authors:  A S Bassett; E W C Chow; J Husted; K A Hodgkinson; E Oechslin; L Harris; C Silversides
Journal:  J Med Genet       Date:  2009-02-25       Impact factor: 6.318

Review 2.  The genomics of schizophrenia: update and implications.

Authors:  Paola Giusti-Rodríguez; Patrick F Sullivan
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

3.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

4.  Interventions for the metabolic syndrome in schizophrenia: a review.

Authors:  Evangelos Papanastasiou
Journal:  Ther Adv Endocrinol Metab       Date:  2012-10       Impact factor: 3.565

Review 5.  Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

Authors:  Kathlyn J Ronaldson
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

6.  High-resolution joint symbolic analysis to enhance classification of the cardiorespiratory system in patients with schizophrenia and their relatives.

Authors:  Steffen Schulz; Jens Haueisen; Karl-Jürgen Bär; Voss Andreas
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2015-02-13       Impact factor: 4.226

7.  Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia.

Authors:  Christoffer Polcwiartek; Kristian Kragholm; Steen M Hansen; Brett D Atwater; Daniel J Friedman; Carlo A Barcella; Claus Graff; Jonas B Nielsen; Adrian Pietersen; Jimmi Nielsen; Peter Søgaard; Christian Torp-Pedersen; Svend E Jensen
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

8.  The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review.

Authors:  Evangelos Papanastasiou
Journal:  Ther Adv Psychopharmacol       Date:  2013-02

9.  The toxicology and comorbidities of fatal cases involving quetiapine.

Authors:  Jennifer L Pilgrim; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2013-02-09       Impact factor: 2.007

Review 10.  Ventricular repolarization measures for arrhythmic risk stratification.

Authors:  Francesco Monitillo; Marta Leone; Caterina Rizzo; Andrea Passantino; Massimo Iacoviello
Journal:  World J Cardiol       Date:  2016-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.